Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-07 2021-07-02 138963
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-14 2021-06-14 139413
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-25 2021-07-22 139848
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-07-23 2021-10-05 142982
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-03 2021-11-08 145150
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-17 2021-10-12 145831
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-21 2021-10-28 145949
APO-DARIFENACIN 7.5MG TABLET (EXTENDED-RELEASE) Resolved 2021-10-01 2022-01-24 146503
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-10-07 2021-12-06 146795
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-09 2022-01-06 148999
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-29 2022-01-29 150181
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2021-12-09 2022-01-24 150839
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-07 2022-01-24 152301
APO-DARIFENACIN 15MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-14 2022-02-03 152758
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-14 2022-02-18 152761
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-14 2022-02-18 152764
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-28 2022-03-24 153783
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-11 2022-04-06 156543
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-11 2022-04-06 156546
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-11 2022-04-06 156549

Showing 2881 to 2900 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ASA LD 81MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60252
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
COATED DAILY LOW DOSE ASA 81 MG 81MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-04 71083
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2019-08-08 60420
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2018-09-15 60438
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2019-08-07 2019-08-07 91117
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4909
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-09-08 2018-09-15 60867

Showing 341 to 356 of 356